These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 15076230)

  • 1. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
    Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
    Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.
    Tabernero A; Schoonjans K; Jesel L; Carpusca I; Auwerx J; Andriantsitohaina R
    BMC Pharmacol; 2002 Apr; 2():10. PubMed ID: 11940253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrane the reduced derivative of fenofibrate.
    Kotheimer AE; Haq W; Balendiran GK
    Results Chem; 2020 Jan; 2():. PubMed ID: 32844085
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA methylation as a marker of response in rheumatoid arthritis.
    Nair N; Wilson AG; Barton A
    Pharmacogenomics; 2017 Sep; 18(14):1323-1332. PubMed ID: 28836487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.
    Yusuf N; Hidalgo B; Irvin MR; Sha J; Zhi D; Tiwari HK; Absher D; Arnett DK; Aslibekyan SW
    Pharmacogenomics; 2017 Sep; 18(14):1333-1341. PubMed ID: 28835163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population.
    Söderström E; Eliasson M; Johnson O; Hallmans G; Weinehall L; Jansson JH; Hultdin J
    Lipids Health Dis; 2013 May; 12():74. PubMed ID: 23697869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.
    Filippatos TD
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):245-55. PubMed ID: 22592524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
    Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
    J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
    Robinson JG
    PPAR Res; 2008; 2008():891425. PubMed ID: 18288293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
    Dierkes J; Luley C; Westphal S
    Vasc Health Risk Manag; 2007; 3(1):99-108. PubMed ID: 17583180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.
    Robinson JG
    Curr Atheroscler Rep; 2007 Jan; 9(1):64-71. PubMed ID: 17169249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of fibrates.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Curr Atheroscler Rep; 2005 Sep; 7(5):396-401. PubMed ID: 16105484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate induces a selective increase of protein-bound homocysteine in rodents: a PPARalpha-mediated effect.
    Legendre C; Caussé E; Chaput E; Salvayre R; Pineau T; Edgar AD
    Biochem Biophys Res Commun; 2002 Aug; 295(5):1052-6. PubMed ID: 12135600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate, homocysteine and renal function.
    Foucher C; Brugère L; Ansquer JC
    Curr Vasc Pharmacol; 2010 Sep; 8(5):589-603. PubMed ID: 20507276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azaribine-homocystinemia-thrombosis in historical perspective.
    Drell W; Welch AD
    Pharmacol Ther; 1989; 41(1-2):195-206. PubMed ID: 2469090
    [No Abstract]   [Full Text] [Related]  

  • 18. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism.
    Luc G; Jacob N; Bouly M; Fruchart JC; Staels B; Giral P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):452-3. PubMed ID: 15076230
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.